A Study to Evaluate the Effect of Enzyme-treated Royal Jelly Consumption on the Index of Hematopoietic Stem Cell Count in Healthy Subjects
- Conditions
- Adult
- Registration Number
- JPRN-UMIN000042951
- Lead Sponsor
- Yamada Bee Company, Inc.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 80
Not provided
1) Subjects with a history of food allergy 2) Subjects with a history of asthma 3) Pregnant women, those who wish to become pregnant, and those who are breast-feeding 4) Those who have participated in other clinical studies within 12 weeks prior to the intake of the test food. 5) Those with a history of major surgery in the gastrointestinal tract, such as gastrectomy, gastrointestinal suture, or intestinal resection (appendicectomy is acceptable) 6) Subjects suffering from serious hepatic disorder, renal/cardiac disease, organ disorder, diabetes, autoimmune disease such as rheumatoid arthritis, systemic lupus erythematosus, or other serious disease 7) Those who are receiving medication (hospital visits or medication prescriptions) 8) Those who are unable to consume test foods as instructed or are unable to maintain rest until the end of the test. 9) Those who are unable to prohibit the daily intake of foods that may affect the test. 10) Those who are unable to maintain a regular lifestyle 11) Those who do not work day shifts (night shifts or rotating shifts) 12) Those who have had blood drawn (e.g., donated blood) in excess of 200 mL within 4 weeks prior to the start of this study or 400 mL within 3 months 13) Those whose normal alcohol consumption exceeds 500 mL of beer equivalent per day. 14) Smokers 15) Subjects with a BMI of less than 18.5 and more than 30 kg/m2 (during the study period) 16) Those who cannot follow the instructions to wear a mask when visiting the hospital 17) Those who have cold symptoms such as fever, taste or smell disorder within 1 week of each observation point 18) Those who have had contact with COVID-19 patients or close contacts within 2 weeks of each observation point 19) Persons who have traveled to or had contact with foreign countries within 2 weeks of each observation point. 20) Other persons who are judged by the investigator to be inappropriate for participation in this study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method